Cannabis Drug Testing Laws in California
California AB 2188 prohibits discrimination based on off-duty cannabis use or nonpsychoactive metabolites, effective January 1, 2024.
Overview
California passed AB 2188 in 2022 (effective Jan 1, 2024), codified at Cal. Gov. Code § 12954. The law makes it unlawful for employers to discriminate in hiring, termination, or any condition of employment based on off-duty cannabis use or the presence of nonpsychoactive cannabis metabolites in drug tests. SB 700 separately prohibits asking applicants about prior cannabis use.
| State | California (CA) |
| Legal Status | Recreational Legal |
| Workplace Protection | Strong Protections |
| Protection Summary | Strong. Employers cannot discriminate based on off-duty, off-premises cannabis use. Employers also cannot use drug tests that detect only nonpsychoactive cannabis metabolites — they must use tests capable of distinguishing impairment. |
| Safety-Sensitive Exemption | Building and construction trades are exempt. Federal background investigation positions are exempt. Federal contractors and federally-regulated workers (DOT, airlines, etc.) remain subject to federal rules. |
| DUI Threshold | No per se THC limit. Impairment-based DUI under Veh. Code § 23152(f). |
| Synthetic Urine Law | Criminalized. |
Key Statutes
- Cal. Gov. Code § 12954 (AB 2188)
- Cal. Gov. Code § 12954.5 (SB 700)
Key Court Cases
- Ross v. RagingWire Telecommunications (Cal. 2008) — superseded by AB 2188. Previously held Compassionate Use Act provided no employment protection.
Practical Notes
California Cannabis Context
California is the largest legal cannabis market in the world and has the most comprehensive workplace protections in the United States. AB 2188 (effective January 1, 2024) was enacted in direct response to decades of cases like Ross v. RagingWire (2008), which held that the Compassionate Use Act provided no employment protection. The new statute explicitly overturns Ross and prohibits discrimination based on off-duty cannabis use or nonpsychoactive metabolites. California also passed SB 700, which prohibits asking job applicants about prior cannabis use.
What makes California's framework unusual is the explicit requirement that employer drug tests cannot rely solely on nonpsychoactive metabolites. This is a direct legislative response to the science: testing for THC-COOH does not measure impairment, only past exposure. Employers must use tests capable of distinguishing recent use or actual impairment — effectively pushing the market toward oral fluid testing, performance testing, and impairment-recognition protocols. Several major California employers have moved to oral fluid testing as a result.
The exemptions in AB 2188 are significant. Building and construction trades are explicitly exempt. Federal background investigation positions are exempt. Federal contractors and DOT-regulated workers (CDL drivers, pilots, transportation workers) remain subject to federal rules regardless of state law. California has nearly 40 million residents and a massive workforce, but a substantial fraction of workers fall into one of these federal categories — particularly in defense, transportation, and federal facility-adjacent industries.
What This Means for You
California is one of the strong-protection states. Private employers in most positions cannot take adverse action against you based on off-duty cannabis use or a positive test for nonpsychoactive metabolites alone. However:
- Federal contractor and DOT positions remain subject to federal rules — see Federal Rules
- Safety-sensitive positions typically fall outside the state protection — see Safety-Sensitive Positions
- Impairment at work is never protected, regardless of the state statute
- Federal employment and security clearances remain off-limits for cannabis users